HDAC8 and hepatocellular carcinoma: Down-regulation of HDAC-8 increases global acetylation and enhancer acetylation of histone H3 lysine 27 (H3K27), thereby reactivating the production of HCC T cell chemokines and alleviating tumor T cell rejection.